Cargando…

Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction

BACKGROUND: We aim to find out the relationship between random blood glucose (RBG), fasting blood glucose (FBG) and in-hospital adverse events in ST-segment elevation acute myocardial infarction (STEMI) patients. We evaluate and compare the predictive value of RBG and FBG on in-hospital adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yuhan, Yan, Gaoliang, Qiao, Yong, Wang, Dong, Luo, Erfei, Hou, Jiantong, Tang, Chengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045631/
https://www.ncbi.nlm.nih.gov/pubmed/32103724
http://dx.doi.org/10.1186/s12872-020-01394-4
_version_ 1783501816106844160
author Qin, Yuhan
Yan, Gaoliang
Qiao, Yong
Wang, Dong
Luo, Erfei
Hou, Jiantong
Tang, Chengchun
author_facet Qin, Yuhan
Yan, Gaoliang
Qiao, Yong
Wang, Dong
Luo, Erfei
Hou, Jiantong
Tang, Chengchun
author_sort Qin, Yuhan
collection PubMed
description BACKGROUND: We aim to find out the relationship between random blood glucose (RBG), fasting blood glucose (FBG) and in-hospital adverse events in ST-segment elevation acute myocardial infarction (STEMI) patients. We evaluate and compare the predictive value of RBG and FBG on in-hospital adverse events, and give an appropriate cut-off value of RBG and FBG. METHOD: A retrospective study enrolled 958 consecutive AMI patients undergoing emergency coronary angiography at Zhongda Hospital were enrolled from January 1, 2016, to December 31, 2018 was performed. RBG and FBG, baseline data and adverse events were recorded. Major adverse cardiovascular and cerebrovascular events (MACCE) were defined as death, nonfatal recurrent myocardial infarction and stroke. Other adverse events included malignant arrhythmia, cardiac shock and hemorrhage. Patients with RBG > 11.1 mmol/L were divided into elevated RBG group. Patients with FBG > 6.1 mmol/L were divided into elevated FBG group. The incidence of in-hospital adverse events were compared in elevated RBG/FBG group and the control group. ROC curve was used to evaluate the predictive value of RBG and FBG on in-hospital adverse events. RESULT: The incidence of death, hemorrhage, cardiac shock and malignant arrhythmia significantly increases in elevated RBG and FBG group. Binary logistic regression showed that age, hypertension, diabetes, FBG and RBG were independent risk factors for in-hospital adverse events in STEMI patients. The AUC and 95% CI of RBG and FBG in predicting death of AMI patients were 0.789, 0.759~0.816; 0.810, 0.783~0.835, respectively. The cut-off values ​were 13.82 and 7.35 mmol/L. RBG and FBG also had fine predictive value on cardiac shock and malignant arrhythmia, no statistical difference was found in the predictive value on in-hospital adverse events (P = 0.462, P = 0.570, P = 0.694). CONCLUSION: Incidence of in-hospital adverse events significantly increases in AMI patients combined with elevated RBG or FBG. Both RBG and FBG were independent risk factors for in-hospital adverse events, they had good value on predicting in-hospital adverse events and there was no statistical difference in their predictive value.
format Online
Article
Text
id pubmed-7045631
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70456312020-03-03 Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction Qin, Yuhan Yan, Gaoliang Qiao, Yong Wang, Dong Luo, Erfei Hou, Jiantong Tang, Chengchun BMC Cardiovasc Disord Research Article BACKGROUND: We aim to find out the relationship between random blood glucose (RBG), fasting blood glucose (FBG) and in-hospital adverse events in ST-segment elevation acute myocardial infarction (STEMI) patients. We evaluate and compare the predictive value of RBG and FBG on in-hospital adverse events, and give an appropriate cut-off value of RBG and FBG. METHOD: A retrospective study enrolled 958 consecutive AMI patients undergoing emergency coronary angiography at Zhongda Hospital were enrolled from January 1, 2016, to December 31, 2018 was performed. RBG and FBG, baseline data and adverse events were recorded. Major adverse cardiovascular and cerebrovascular events (MACCE) were defined as death, nonfatal recurrent myocardial infarction and stroke. Other adverse events included malignant arrhythmia, cardiac shock and hemorrhage. Patients with RBG > 11.1 mmol/L were divided into elevated RBG group. Patients with FBG > 6.1 mmol/L were divided into elevated FBG group. The incidence of in-hospital adverse events were compared in elevated RBG/FBG group and the control group. ROC curve was used to evaluate the predictive value of RBG and FBG on in-hospital adverse events. RESULT: The incidence of death, hemorrhage, cardiac shock and malignant arrhythmia significantly increases in elevated RBG and FBG group. Binary logistic regression showed that age, hypertension, diabetes, FBG and RBG were independent risk factors for in-hospital adverse events in STEMI patients. The AUC and 95% CI of RBG and FBG in predicting death of AMI patients were 0.789, 0.759~0.816; 0.810, 0.783~0.835, respectively. The cut-off values ​were 13.82 and 7.35 mmol/L. RBG and FBG also had fine predictive value on cardiac shock and malignant arrhythmia, no statistical difference was found in the predictive value on in-hospital adverse events (P = 0.462, P = 0.570, P = 0.694). CONCLUSION: Incidence of in-hospital adverse events significantly increases in AMI patients combined with elevated RBG or FBG. Both RBG and FBG were independent risk factors for in-hospital adverse events, they had good value on predicting in-hospital adverse events and there was no statistical difference in their predictive value. BioMed Central 2020-02-27 /pmc/articles/PMC7045631/ /pubmed/32103724 http://dx.doi.org/10.1186/s12872-020-01394-4 Text en © The Author(s) 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Qin, Yuhan
Yan, Gaoliang
Qiao, Yong
Wang, Dong
Luo, Erfei
Hou, Jiantong
Tang, Chengchun
Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction
title Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction
title_full Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction
title_fullStr Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction
title_full_unstemmed Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction
title_short Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction
title_sort predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with st-segment elevation acute myocardial infarction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045631/
https://www.ncbi.nlm.nih.gov/pubmed/32103724
http://dx.doi.org/10.1186/s12872-020-01394-4
work_keys_str_mv AT qinyuhan predictivevalueofrandombloodglucoseversusfastingbloodglucoseoninhospitaladverseeventsinpatientswithstsegmentelevationacutemyocardialinfarction
AT yangaoliang predictivevalueofrandombloodglucoseversusfastingbloodglucoseoninhospitaladverseeventsinpatientswithstsegmentelevationacutemyocardialinfarction
AT qiaoyong predictivevalueofrandombloodglucoseversusfastingbloodglucoseoninhospitaladverseeventsinpatientswithstsegmentelevationacutemyocardialinfarction
AT wangdong predictivevalueofrandombloodglucoseversusfastingbloodglucoseoninhospitaladverseeventsinpatientswithstsegmentelevationacutemyocardialinfarction
AT luoerfei predictivevalueofrandombloodglucoseversusfastingbloodglucoseoninhospitaladverseeventsinpatientswithstsegmentelevationacutemyocardialinfarction
AT houjiantong predictivevalueofrandombloodglucoseversusfastingbloodglucoseoninhospitaladverseeventsinpatientswithstsegmentelevationacutemyocardialinfarction
AT tangchengchun predictivevalueofrandombloodglucoseversusfastingbloodglucoseoninhospitaladverseeventsinpatientswithstsegmentelevationacutemyocardialinfarction